medicin
maxim
ounc
prevent
worth
pound
cure
play
pivot
role
efficaci
costeffect
patient
care
asthma
pathogenesi
root
atopi
airway
hyperrespons
treat
part
knowledg
subsequ
avoid
variou
trigger
although
asthma
associ
allerg
diathesi
allerg
trigger
true
partli
true
subset
patient
articl
review
familiar
allerg
trigger
manag
comorbid
associ
worsen
asthma
even
mimic
asthma
without
true
bronchial
hyperrespons
mani
patient
one
factor
trigger
asthma
optim
control
obtain
patient
health
care
team
work
togeth
prevent
exposur
amelior
aggrav
condit
environment
allergen
pollen
dust
mite
pet
dander
mold
allerg
patient
asthma
trigger
mimic
asthma
symptom
laryngopharyng
reflux
lpr
also
known
gastroesophag
reflux
diseas
gerd
exercis
irrit
tobacco
smoke
industri
pollut
food
allergi
viral
infect
pharmacolog
agent
aspirin
bblocker
paradox
vocal
fold
dysfunct
pvfd
associ
investig
includ
obes
stress
hormon
statu
initi
assess
patient
follow
systemat
seri
question
identifi
possibl
exacerb
factor
fig
preliminarili
identifi
specif
trigger
elicit
appropri
algorithm
inquiri
necessari
identifi
precipit
factor
optim
direct
therapi
avoid
evalu
irrit
allerg
exposur
trigger
includ
amount
exposur
patient
sensit
specif
allergen
place
exposur
asthma
trigger
home
work
school
clinic
signific
sensit
relat
patient
medic
histori
unlik
environment
allergen
clinician
part
guid
allergi
test
result
irrit
workplac
chemic
cigarett
smoke
trigger
asthma
nonig
mediat
mechan
often
difficult
definit
identifi
culprit
beyond
fact
patient
develop
symptom
enter
workplac
reliev
home
anoth
environ
formaldehyd
outgass
new
construct
carpet
also
trigger
symptom
poorli
ventil
area
patient
reach
particularli
high
level
mobil
home
glutaraldehyd
commonli
use
disinfect
endoscop
trigger
workplac
allergen
play
key
role
mani
patient
allergi
trigger
acut
exacerb
underli
longterm
effect
control
allergen
activ
mast
cell
bound
ige
lead
releas
bronchoconstrictor
mediat
result
bronchial
narrow
character
asthma
symptom
allerg
rhiniti
common
allergen
trigger
slight
differ
effect
includ
dermatophagoid
speci
dust
mite
caus
perenni
lowgrad
chronic
symptom
domest
anim
cat
dog
cockroach
caus
perenni
symptom
grass
ragwe
tree
pollen
fungal
spore
season
often
caus
allerg
rhiniti
rather
asthma
symptom
environment
factor
thunderstorm
increas
amount
pollen
air
attribut
condit
begin
storm
caus
pollen
grain
ruptur
dispers
air
recommend
appli
gener
allergen
asthma
trigger
follow
systemat
approach
identif
allergen
environment
control
rang
simpl
complex
water
damag
exist
patient
dwell
patient
reactiv
mold
correct
water
leak
damag
remedi
mold
requisit
improv
patient
health
quit
expens
howev
dust
mite
cockroach
trigger
pillow
mattress
allergen
cover
coupl
hot
water
weekli
wash
bed
cover
may
suffic
former
visit
pest
control
compani
schedul
basi
may
resolv
latter
except
obviou
case
allergi
skin
vitro
test
ige
specif
antigen
best
way
identifi
potenti
allergen
everi
posit
test
repres
clinic
import
allergen
exampl
nhane
studi
popul
demonstr
skin
allergi
test
posit
dust
mite
wherea
popul
allerg
similarli
allergen
note
clinic
patient
neg
skin
test
posit
nasal
provoc
assess
nasalspecif
ige
allergen
complet
avoid
possibl
limit
exposur
attempt
way
complet
avoid
limit
exposur
third
option
patient
take
extra
dose
bronchodil
antihistamin
predict
trigger
exposur
undergo
desensit
therapi
either
allergi
shot
sublingu
drop
one
common
trigger
acut
exacerb
upper
respiratori
tract
infect
rhinoviru
respiratori
syncyti
viru
coronaviru
viral
infect
poorli
understood
mechan
result
increas
number
eosinophil
neutrophil
peopl
asthma
addit
may
reduc
identifi
asthma
trigger
product
type
interferon
respiratori
epitheli
cell
thu
increas
suscept
viral
infect
result
greater
inflammatori
respons
infect
occur
patient
may
present
infect
includ
cold
influenza
respiratori
syncyti
viru
airway
inflamm
concomit
increas
mucu
product
patient
asthma
viral
infect
exacerb
inflamm
persist
long
viral
part
infect
resolv
viral
infect
may
also
increas
patient
suscept
develop
new
allerg
sensit
patient
recommend
avoid
infect
follow
advic
applic
patient
especi
import
peopl
asthma
patient
inform
import
wash
hand
avoid
sick
contact
get
adequ
sleep
use
prescrib
medic
symptomat
treatment
infect
intranas
glucocorticoid
decongest
recommend
peopl
asthma
get
yearli
intramuscular
flu
vaccin
evid
peopl
asthma
other
chronic
obstruct
pulmonari
diseas
may
benefit
pneumococc
vaccin
reduct
morbid
mortal
group
gerd
lpr
gerd
lpr
commonli
encount
comorbid
seen
peopl
asthma
one
review
studi
gerd
symptom
seen
abnorm
ph
test
hiatal
hernia
esophag
symptom
lpr
includ
heartburn
regurgit
dysphagia
chest
pain
hoars
dental
eros
worsen
supin
posit
worsen
factor
eat
alcohol
theophyllin
system
badrenerg
agonist
bronchodil
lower
esophag
sphincter
tone
acid
reflux
may
caus
bronchoconstrict
three
propos
mechan
increas
vagal
tone
sensit
bronchial
reactiv
microaspir
gastric
content
upper
airway
patient
recommend
signific
lpr
control
asthma
symptom
variabl
outcom
variou
trial
recommend
split
two
group
patient
symptomat
lpr
patient
asymptomat
patient
symptomat
lpr
may
benefit
proton
pump
inhibitor
ppi
primarili
patient
subject
criteria
base
studi
qualiti
life
questionnair
reduc
number
asthma
exacerb
studi
show
improv
pulmonari
function
patient
asthma
gerd
control
ppi
show
minor
improv
patient
asthma
clinic
silent
lpr
ppi
therapi
shown
benefit
asthma
outcom
conclud
situat
difficulttocontrol
asthma
like
gerd
approach
identifi
patient
like
benefit
ppi
therapi
symptom
regurgit
nocturn
asthma
importantli
concurr
symptom
lpr
asthma
patient
addit
follow
recommend
given
patient
lpr
includ
rais
head
bed
night
inch
eat
hour
lie
supin
posit
avoid
fatti
food
chocol
peppermint
excess
alcohol
reduct
abdomin
obes
clinic
suspicion
lpr
high
trial
ppi
given
patient
improv
clinic
test
undertaken
esophag
ph
test
help
determin
caus
import
medic
awar
trigger
reactiv
airway
nonselect
bblocker
aspirin
nonsteroid
antiinflammatori
drug
nsaid
although
potenti
nonselect
bblocker
contraind
peopl
asthma
asthma
peopl
asthma
nasal
polyp
trigger
aspirin
nsaid
patient
classifi
aspirinexacerb
respiratori
diseas
aerd
also
commonli
known
samter
triad
asthma
aspirin
sensit
nasal
polyp
reaction
nsaid
aerd
classifi
pseudoallerg
typic
igemedi
reaction
rather
base
common
abil
nsaid
aspirin
inhibit
cyclooxygenas
cox
enzym
pathophysiolog
aerd
incomplet
understood
like
relat
overproduct
proinflammatori
arachiadon
acid
product
especi
leukotrien
support
fact
medic
inhibit
leukotrien
synthesi
leukotrien
receptor
antagonist
eg
zileuton
montelukast
reduc
elimin
bronchoconstrict
respons
aspirin
diagnosi
aerd
base
initi
clinic
featur
present
samter
triad
present
diagnosi
rel
unambigu
often
part
triad
present
part
develop
slowli
time
make
associ
difficult
suspicion
nsaid
reaction
arous
physician
question
patient
nsaid
use
first
suspect
reaction
whether
reaction
occur
point
reason
nsaid
sensit
acquir
thu
prior
nonreact
relev
aspirin
challeng
way
definit
diagnos
nsaid
sensit
likelihood
posit
oral
aspirin
challeng
histori
singl
nsaid
reaction
increas
histori
two
reaction
aspirin
challeng
need
case
patient
ongo
regular
need
nsaid
therapi
rheumatolog
diseas
cardiovascular
diseas
patient
refer
allergi
pulmonari
specialist
test
patient
recommend
aerd
includ
typic
asthma
therapi
avoid
nsaid
aspirin
desensit
follow
daili
aspirin
therapi
pharmacolog
therapi
includ
leukotrien
modifi
agent
result
better
asthma
control
medium
high
dose
glucocorticoid
alon
altern
medic
use
safe
acetaminophen
dose
mg
awar
patient
react
dose
mg
highli
select
inhibitor
celecoxib
aspirin
desensit
instanc
need
accomplish
nearli
patient
aerd
desensit
patient
must
continu
take
aspirin
daili
maintain
desensit
state
nonselect
bblocker
anoth
class
medic
present
problem
patient
asthma
asthma
bblocker
caus
increas
bronchial
obstruct
airway
reactiv
importantli
blunt
effect
inhal
oral
breceptor
agonist
albuterol
play
key
role
treatment
acut
asthma
exacerb
peopl
asthma
without
concomit
cardiovascular
diseas
routin
use
even
cardioselect
bblocker
treatment
hypertens
avoid
studi
shown
moder
stabl
asthma
select
bblocker
may
use
low
dose
requir
close
physician
supervis
import
physician
understand
although
evid
support
use
bblocker
improv
surviv
patient
chronic
obstruct
pulmonari
diseas
possibl
result
cardiopulmonari
protect
properti
current
appli
patient
asthma
base
current
review
literatur
angiotensinconvert
enzym
inhibitor
deserv
discuss
relat
asthma
trigger
primarili
point
common
side
effect
occur
dri
hack
cough
easili
mistaken
worsen
asthma
symptom
independ
asthma
patient
switch
angiotensin
receptor
blocker
lower
incid
dri
cough
plethora
inhal
irrit
pollut
peopl
asthma
made
awar
increas
asthma
exacerb
includ
limit
tobacco
smoke
fireplac
smoke
ash
aerosol
perfum
cook
odor
musti
odor
shower
steam
traffic
pollut
air
pollut
dust
workplac
irrit
cigarett
smoke
wellstudi
airway
irrit
known
caus
asthma
sever
symptom
increas
rate
hospit
acceler
declin
lung
function
impair
respons
inhal
system
glucocorticoid
compar
nonsmok
interestingli
develop
countri
approxim
adult
asthma
current
cigarett
smoker
similar
rate
gener
popul
patient
popul
present
uniqu
issu
treatment
reduc
respons
shortterm
corticosteroid
therapi
normal
play
import
role
typic
treatment
regimen
mechan
glucocorticoid
resist
fulli
explain
postul
caus
chang
airway
inflammatori
cell
phenotyp
chang
glucocorticoid
receptor
alpha
beta
ratio
reduc
histon
deacetylas
activ
strongest
recommend
smoker
asthma
educ
patient
variou
method
avail
help
quit
smoke
best
efficaci
shown
week
smoke
cessat
consider
improv
lung
function
fall
sputum
neutrophil
count
occur
unfortun
still
remain
difficult
maintain
smoke
cessat
peopl
asthma
chronic
smoker
avenu
often
trial
asthma
drug
addit
glucocorticoid
preliminari
data
leukotrienereceptor
antagonist
may
benefit
smoker
mild
asthma
patient
disord
acut
symptomat
even
requir
intub
emerg
set
intub
monitor
pulmonari
function
demonstr
absolut
normal
patholog
asthma
impost
pulmonari
tree
rather
paradox
closur
adduct
vocal
cord
inspir
intub
obstruct
bypass
pvfd
usual
present
intermitt
may
observ
video
endoscopi
larynx
unless
trigger
exercis
stress
help
diagnost
question
short
breath
inspir
expir
patient
pvfd
answer
breath
wherea
patient
asthma
problem
expir
breath
exercis
voic
therapi
help
treat
pvfd
emot
state
stress
depress
known
influenc
level
asthma
control
variou
studi
shown
children
grow
chronic
stress
environ
higher
preval
asthma
stronger
correl
seen
atop
asthma
stress
anxieti
depress
versu
nonatop
asthma
recommend
emot
trigger
patient
recogn
manag
accordingli
appropri
medic
psychotherapi
social
work
best
allevi
stressor
posit
correl
obes
increas
preval
incid
asthma
reduc
asthma
control
prospect
cohort
studi
individu
demonstr
linear
correl
bodi
mass
index
adultonset
asthma
incid
mechan
incomplet
understood
signific
portion
attribut
chronic
lowgrad
system
inflamm
function
increas
amount
function
adipos
tissu
result
releas
variou
cytokin
chemokin
solubl
fraction
receptor
recent
studi
show
increas
eosinophil
activ
associ
high
serum
leptin
tumor
necrosi
factora
level
atop
obes
children
adolesc
asthma
compar
nonobes
healthi
volunt
mechan
obes
individu
reduc
lung
function
mechan
decreas
function
residu
capac
lung
volum
tidal
volum
addit
myriad
comorbid
condit
associ
obes
dyslipidemia
gerd
type
diabet
hypertens
complic
manag
recommend
patient
asthma
counsel
benefit
weight
loss
method
avail
last
year
unifi
airway
model
interrelated
pathophysiolog
process
upper
airway
influenc
lower
airway
shape
therapi
direct
target
known
nasal
obstruct
trigger
asthma
exacerb
particularli
problemat
patient
nasal
polyp
preendoscop
postendoscop
sinu
surgeri
review
patient
chronic
rhinosinus
concomit
asthma
improv
symptom
reduct
emerg
room
visit
medic
result
wherea
two
patient
improv
requir
revis
surgeri
nasal
polyp
addit
intens
accumul
inflammatori
materi
sinus
hypothes
feed
fuel
lower
airway
inflamm
improv
chronic
rhinosinus
either
establish
nasal
breath
reduc
inflammatori
drip
improv
symptomat
asthma
patient
arm
knowledg
diseas
process
identifi
trigger
exacerb
factor
best
abl
partner
health
care
team
prevent
exposur
trigger
asthmat
exacerb
control
symptom
import
treat
prevent
asthma
understand
mani
patient
one
trigger
may
multipl
trigger
